EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company is headquartered in Vancouver, Canada.
Stock data | 2025 | Change |
---|---|---|
Price | $0.11896907199998887 | N/A |
Market Cap | $1.36M | N/A |
Shares Outstanding | 11.39M | N/A |
Employees | 0 | N/A |